Real-world 24-month pain outcomes of disk percutaneous ablation and extraction versus Disc-FX nucleoplasty for lumbar discogenic pain and contained lumbar disk herniation: a single-center retrospective cohort study - Summary - MDSpire
Advertisement
Real-world 24-month pain outcomes of disk percutaneous ablation and extraction versus Disc-FX nucleoplasty for lumbar discogenic pain and contained lumbar disk herniation: a single-center retrospective cohort study
To compare mid-to-long-term clinical outcomes of Disk Percutaneous Ablation and Extraction (DPAE) and standard Disc-FX in patients with lumbar discogenic pain and contained herniation.
Approach:
Key Findings:
DPAE group had a mean VAS reduction of 5.29 ± 2.06 vs. 4.17 ± 2.24 in Disc-FX group (p < 0.001).
DPAE showed better improvement in ODI, higher PGIC marked improvement, and higher composite success rate (70.0% vs. 51.1%, p < 0.05).
Reintervention rate was lower in DPAE group (7.3%) compared to Disc-FX (14.8%), with a reduced risk (HR = 0.46, p = 0.047).
Complication rates were similar between groups (6.4% vs. 9.1%).
Interpretation:
Limitations:
Single-center study may limit generalizability.
Retrospective design may introduce selection bias.
Conclusion:
Future multicenter prospective studies are warranted to validate the long-term efficacy of DPAE and define optimal indications.
A Geneva registry study points surgeons toward residual pain over functional limitation as the outcome that tracks patient satisfaction one year after hip or knee replacement.
Acidic gum beat sugar-free at cranking out nitric oxide from beetroot juice — exactly backward from what test-tube studies predicted. Also this week: a sleep gene that ignores amyloid, and jackfruit sap moonlighting as a bone-building drug delivery system.
